FUB-PB-22

Add links
Source: Wikipedia, the free encyclopedia.
FUB-PB-22
Legal status
Legal status
Identifiers
  • quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate
JSmol)
  • Fc1ccc(cc1)Cn1cc(c2c1cccc2)C(=O)Oc1cccc2c1nccc2
  • InChI=1S/C25H17FN2O2/c26-19-12-10-17(11-13-19)15-28-16-21(20-7-1-2-8-22(20)28)25(29)30-23-9-3-5-18-6-4-14-27-24(18)23/h1-14,16H,15H2
  • Key:ROHVURVXAOMRJY-UHFFFAOYSA-N

FUB-PB-22 (QUFUBIC) is an

CB1 receptor and has been sold online as a designer drug.[1][2]

Pharmacology

FUB-PB-22 acts as a

CB2 cannabinoid receptors.[3]

Legal status

FUB-PB-22 is an Anlage II controlled substance in Germany. It was scheduled in Japan in July 2014.

As of October 2015 FUB-PB-22 is a controlled substance in China.[4]

It is also banned in Sweden.[5]

See also

References

  1. ^ "FUB-PB-22". Southern Association of Forensic Scientists. Archived from the original on 27 May 2015. Retrieved 23 July 2015.
  2. PMID 26257833
    .
  3. PMID 27429655
    .
  4. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
  5. ^ "Cannabinoider föreslås bli klassificerade som hälsofarlig vara". Folkhälsomyndigheten. 28 May 2014. Retrieved 23 July 2015.
Retrieved from "https://en.wikipedia.org/w/index.php?title=FUB-PB-22&oldid=1082423555"